Pricing Table
Kit Size | Dosage per Vial | Total Peptide | Your Price | Price per mg |
---|---|---|---|---|
Single Vial | 5mg | 5mg | $200 | $40.00/mg |
Single Vial | 10mg | 10mg | $220 | $22.00/mg |
Single Vial | 30mg | 30mg | $330 | $11.00/mg |
Single Vial | 60mg | 60mg | $370 | $6.17/mg |
10 Vials | 5mg | 50mg | $240 | $4.80/mg |
10 Vials | 10mg | 100mg | $280 | $2.80/mg |
10 Vials | 15mg | 150mg | $380 | $2.53/mg |
10 Vials | 20mg | 200mg | $450 | $2.25/mg |
10 Vials | 30mg | 300mg | $550 | $1.83/mg |
10 Vials | 50mg | 500mg | $720 | $1.44/mg |
10 Vials | 60mg | 600mg | $770 | $1.28/mg |
Quick Product Specs
- Purity: ≥99%
- Form: Lyophilized Powder
- CAS Number: 2381089-83-2
- Storage: -20°C (freezer)
- Shelf Life: 24 months unopened
- Type: Triple GIP/GLP-1/Glucagon Receptor Agonist
What is Retatrutide?
Retatrutide is a groundbreaking triple receptor agonist that simultaneously activates GIP, GLP-1, and glucagon receptors. This tri-agonist approach represents the cutting edge of metabolic peptide research, combining the benefits of incretin activity with glucagon-mediated energy expenditure. Retatrutide has shown remarkable promise in research for substantial weight reduction and metabolic improvements, potentially offering advantages over dual-agonist peptides through its unique three-pathway activation mechanism.
Research Applications
- Triple receptor agonism mechanism studies
- Advanced energy expenditure research
- Maximum weight regulation investigation
- Metabolic flexibility and adaptation studies
- Novel therapeutic mechanism research
- Comparative multi-agonist analysis
- Body composition transformation research